MA33765B1 - Nouvelles formes polymorphes de {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate de méthyle - Google Patents
Nouvelles formes polymorphes de {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate de méthyleInfo
- Publication number
- MA33765B1 MA33765B1 MA34894A MA34894A MA33765B1 MA 33765 B1 MA33765 B1 MA 33765B1 MA 34894 A MA34894 A MA 34894A MA 34894 A MA34894 A MA 34894A MA 33765 B1 MA33765 B1 MA 33765B1
- Authority
- MA
- Morocco
- Prior art keywords
- fluorobenzyl
- pyrazolo
- pyrimidin
- diamino
- pyridin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
L'invention concerne de nouvelles formes de {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate de méthyle de formule (i), en particulier la modification i, un procédé permettant de les fabriquer, des médicaments les contenant ainsi que leur utilisation pour la lutte contre les maladies.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09177373 | 2009-11-27 | ||
EP09177908 | 2009-12-03 | ||
PCT/EP2010/067985 WO2011064189A1 (fr) | 2009-11-27 | 2010-11-23 | Nouvelles formes polymorphes de {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate de méthyle |
Publications (1)
Publication Number | Publication Date |
---|---|
MA33765B1 true MA33765B1 (fr) | 2012-11-01 |
Family
ID=43530231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA34894A MA33765B1 (fr) | 2009-11-27 | 2012-05-25 | Nouvelles formes polymorphes de {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate de méthyle |
Country Status (21)
Country | Link |
---|---|
US (1) | US20110183999A1 (fr) |
EP (1) | EP2504337A1 (fr) |
JP (1) | JP2013512213A (fr) |
KR (1) | KR20120098816A (fr) |
CN (1) | CN102741246A (fr) |
AR (1) | AR079136A1 (fr) |
AU (1) | AU2010323245A1 (fr) |
BR (1) | BR112012012458A2 (fr) |
CA (1) | CA2781808A1 (fr) |
CO (1) | CO6541577A2 (fr) |
CU (1) | CU20120081A7 (fr) |
DO (1) | DOP2012000142A (fr) |
EA (1) | EA201270629A1 (fr) |
EC (1) | ECSP12011923A (fr) |
IL (1) | IL219826A0 (fr) |
MA (1) | MA33765B1 (fr) |
MX (1) | MX2012005944A (fr) |
TN (1) | TN2012000258A1 (fr) |
TW (1) | TW201139433A (fr) |
UY (1) | UY33040A (fr) |
WO (1) | WO2011064189A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2504334E (pt) | 2009-11-27 | 2014-12-03 | Bayer Ip Gmbh | Processo para a purificação de metil-{4,6-diamino-2-[1-(2- fluorobenzil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5- il}metilcarbamato |
DE102010021637A1 (de) | 2010-05-26 | 2011-12-01 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung |
DE102010043379A1 (de) | 2010-11-04 | 2012-05-10 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung |
DE102010043380A1 (de) | 2010-11-04 | 2012-05-10 | Bayer Schering Pharma Aktiengesellschaft | Benzyl-substituierte Carbamate und ihre Verwendung |
RS55387B1 (sr) * | 2011-11-25 | 2017-03-31 | Adverio Pharma Gmbh | Postupak za dobijanje supstituisanih (z)-alfa-fluoro-beta-amino-akrilaldehida |
MX2015010725A (es) | 2013-02-21 | 2016-05-31 | Adverio Pharma Gmbh | Formas de metil {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo [3,4-b] piridino-3-il] pirimidino-5-il} metil carbamato. |
CN104327107A (zh) | 2013-10-17 | 2015-02-04 | 广东东阳光药业有限公司 | 一种氟喹诺酮类抗菌药物的制备方法 |
WO2019078233A1 (fr) * | 2017-10-19 | 2019-04-25 | 株式会社佐藤園 | Composition pour améliorer les capacités d'apprentissage et de mémoire |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19834047A1 (de) * | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
DE19834044A1 (de) * | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
US6452805B1 (en) * | 1999-09-29 | 2002-09-17 | Silicon Graphics, Inc. | Computer module mounting system and method |
DE10220570A1 (de) * | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
US7137037B2 (en) * | 2003-03-27 | 2006-11-14 | Silicon Motion, Inc. | Data storage system and method for testing the same |
DE102006021733A1 (de) * | 2006-05-09 | 2007-11-22 | Bayer Healthcare Ag | 3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung |
-
2010
- 2010-11-19 UY UY0001033040A patent/UY33040A/es not_active Application Discontinuation
- 2010-11-23 CA CA2781808A patent/CA2781808A1/fr not_active Abandoned
- 2010-11-23 MX MX2012005944A patent/MX2012005944A/es not_active Application Discontinuation
- 2010-11-23 EA EA201270629A patent/EA201270629A1/ru unknown
- 2010-11-23 WO PCT/EP2010/067985 patent/WO2011064189A1/fr active Application Filing
- 2010-11-23 EP EP10784755A patent/EP2504337A1/fr not_active Withdrawn
- 2010-11-23 KR KR1020127016595A patent/KR20120098816A/ko not_active Application Discontinuation
- 2010-11-23 AU AU2010323245A patent/AU2010323245A1/en not_active Abandoned
- 2010-11-23 CN CN2010800537098A patent/CN102741246A/zh active Pending
- 2010-11-23 BR BR112012012458A patent/BR112012012458A2/pt not_active IP Right Cessation
- 2010-11-23 JP JP2012540395A patent/JP2013512213A/ja active Pending
- 2010-11-24 AR ARP100104328A patent/AR079136A1/es unknown
- 2010-11-26 TW TW099140894A patent/TW201139433A/zh unknown
- 2010-11-29 US US12/954,961 patent/US20110183999A1/en not_active Abandoned
-
2012
- 2012-05-16 IL IL219826A patent/IL219826A0/en unknown
- 2012-05-24 CU CU2012000081A patent/CU20120081A7/es unknown
- 2012-05-24 EC ECSP12011923 patent/ECSP12011923A/es unknown
- 2012-05-24 DO DO2012000142A patent/DOP2012000142A/es unknown
- 2012-05-24 CO CO12085982A patent/CO6541577A2/es not_active Application Discontinuation
- 2012-05-24 TN TNP2012000258A patent/TN2012000258A1/en unknown
- 2012-05-25 MA MA34894A patent/MA33765B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
US20110183999A1 (en) | 2011-07-28 |
IL219826A0 (en) | 2012-07-31 |
EA201270629A1 (ru) | 2013-01-30 |
EP2504337A1 (fr) | 2012-10-03 |
CO6541577A2 (es) | 2012-10-16 |
UY33040A (es) | 2011-06-30 |
DOP2012000142A (es) | 2013-01-15 |
AU2010323245A1 (en) | 2012-06-14 |
TW201139433A (en) | 2011-11-16 |
ECSP12011923A (es) | 2012-07-31 |
WO2011064189A1 (fr) | 2011-06-03 |
MX2012005944A (es) | 2012-10-03 |
CU20120081A7 (es) | 2012-10-15 |
TN2012000258A1 (en) | 2013-12-12 |
JP2013512213A (ja) | 2013-04-11 |
KR20120098816A (ko) | 2012-09-05 |
AR079136A1 (es) | 2011-12-28 |
CA2781808A1 (fr) | 2011-06-03 |
BR112012012458A2 (pt) | 2017-10-10 |
CN102741246A (zh) | 2012-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA33765B1 (fr) | Nouvelles formes polymorphes de {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate de méthyle | |
SMT201400123B (it) | Imidazo[1,2B]piridazine sostituite come inibitori di trk-chinasi | |
UY33801A (es) | COMPUESTOS SUSTITUIDOS DE N-(1H-INDAZOL-4IL)IMIDAZO[1,2-a]PIRIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE LA TIROSINA QUINASA RECEPTORA DE TIPO III | |
DK3415515T3 (da) | Fremgangsmåde til fremstilling af methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamat | |
SMT201400142B (it) | Composti di N-(1H-indazol-4-il) immidazo[1,2-A]piridin-3-carbossammide sostituita come inibitori di cfms | |
UY34352A (es) | 3-pirimidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante | |
SMP200900085B (it) | 3-imidazolil-indoli per il trattamento di malattieproliferative. | |
EA201270149A1 (ru) | Ингибиторы bace | |
HK1217488A1 (zh) | -二氨基- -氟苄基 -吡唑并 吡啶- -基 嘧啶- -基}甲基氨基甲酸甲酯的形式 | |
PL2126020T3 (pl) | Hydrofobowo modyfikowane polialkilenoiminy jako inhibitory przenoszenia barwnika | |
CU24155B1 (es) | DERIVADOS DE 1-(5,6-DIHIDROIMIDAZO(1,2-a)PIRAZIN-7(8H)-IL )ETANONA | |
DK2124944T3 (da) | Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer | |
BR112012008053A2 (pt) | fermentação purificação de heparosano k5. | |
BRPI0815673A2 (pt) | Sulfonas cíclicas substituídas por aminobenzila úteis como inibidores de bace. | |
IL219712A0 (en) | Novel solvates of methyl {4, 6 -diamino-2-[1-(2-fluorobenzyl)- 1h-pyrazolo[3,4-b] pyridin - 3 - yl] pyrimidin - 5 -yl} carbamate | |
ITMI20080195A1 (it) | Procedimento per la preparazione di solifenacin | |
BRPI1012581A2 (pt) | derivados de amidas de ácido 6, 7-di-hidro-5h-imidazol[1,2-a]imidazol-3-carboxílico | |
ITRM20080037A1 (it) | Procedimento per la ultrapurificazione di alginati. | |
IT1392158B1 (it) | Procedimento per la preparazione di additivi per lubrificanti, contenenti cerio | |
DK1835912T3 (da) | Substituerede benzimidazoler til behandling af histomoniasis | |
UA43602U (ru) | Применение производных 1,2,3-триазол(1н) -4-карбоновых кислот как ноотропных средств | |
TH118223B (th) | อนุพันธ์ของ 6,7-ไดไฮโดร-5H-อิมิแดโซ[1,2-a]อิมิแดโซล-3-คาร์บอกซิลิค แอซิด แอมีด | |
PA8734601A1 (es) | Proceso para preparar 2-metil-1-(2-metilpropil)-1h-imidazo[4,5-c][1,5]naftiridin-4-amina | |
BRPI0906985A2 (pt) | Derivados de pirido[4,3-d]pirimidinona como inibidores de cinase | |
UA38064U (ru) | Применение производных 2-оксоиндолин-3-глиоксиловой кислоты как средств ноотропного действия |